过去一年中添加的文章，按日期排序
Acsm5 C. 1273c> A Mutation Promotes Malignant Progression of Lung Adenocarcinoma in Xuanwei Region
C He, H Zhang, X Wang, M Zhong, H Shi, Y Li… - Available at SSRN … - papers.ssrn.com
28 天前 - … mutations in Xuanwei lung cancer still focuses on the celebrity gene … gene mutation
for Xuanwei lung cancer. In order to 74 … Xuanwei LUAD, this study combined transcriptome …
for Xuanwei lung cancer. In order to 74 … Xuanwei LUAD, this study combined transcriptome …
Using Biomarkers to Characterize Exposures to Diesel Exhaust and Smoky Coal
SS Lu - 2024 - search.proquest.com
35 天前 - … levels along with lower lung cancer rates in the … lung cancer risks in Xuanwei.Moreover,
the prevalence of G to T transversions in driver genes in lung cancer tissue of Xuanwei …
the prevalence of G to T transversions in driver genes in lung cancer tissue of Xuanwei …
Application Research of Serum miR-4646-5p, miR-3654 Combined with Traditional Lung Cancer Tumor Markers in the Diagnosis of Lung Cancer in Xuanwei, Yunnan …
R Zhang, X Wan, X Huang, M Li… - … of lung cancer, 2024 - pubmed.ncbi.nlm.nih.gov
47 天前 - … Xuanwei lung cancer. Combined with miR-4646-5p and CEA, its diagnostic value
for Xuanwei lung cancer … , making it a promising screening indicator for Xuanwei lung cancer. …
for Xuanwei lung cancer … , making it a promising screening indicator for Xuanwei lung cancer. …
Analysis of driver gene mutations in “Xuanwei” multi-nodular non-small cell lung cancer
X WANG, Q LI, Z SHEN, J CAI, Z LI… - … Journal of Cancer …, 2024 - pesquisa.bvsalud.org
62 天前 - @#[摘 要] 目的: 探讨多结节非小细胞肺癌 (NSCLC) 组织中的驱动基因突变情况与临床
病理特征的关系, 为多结节 NSCLC 患者治疗提供分子诊断依据. 方法: 本研究共纳入 2018 年 1 …
病理特征的关系, 为多结节 NSCLC 患者治疗提供分子诊断依据. 方法: 本研究共纳入 2018 年 1 …
Plasma concentration estimates of thirty trace elements in Xuanwei and Fuyuan, two high lung cancer incidence areas in China
L Zhang, Y Ge, J Lv - Trace Elements and Electrolytes, 2024 - search.proquest.com
81 天前 - … lung cancer cases living in Xuanwei and Fuyuan for at least 1 year as participants
for the lung cancer … Matched controls were selected from noncancer patients within the same …
for the lung cancer … Matched controls were selected from noncancer patients within the same …
[HTML][HTML] Expanded PAH analysis of household air pollution in a rural region of China with high lung cancer incidence
Y Zhang, K Meliefste, W Hu, L Portengen… - Environmental …, 2024 - Elsevier
85 天前 - … in Xuanwei and Fuyuan counties, China, is responsible for some of the highest lung
cancer … Here we describe measurements of mPAHs in Xuanwei and Fuyuan derived from …
cancer … Here we describe measurements of mPAHs in Xuanwei and Fuyuan derived from …
Epigenome-wide association study of household air pollution exposure in an area with high lung cancer incidence.
97 天前 - … of lung cancer among never-smoking women in Xuanwei, … To elucidate molecular
mechanisms driving lung cancer in … into the pathogenesis of lung cancer in this population, …
mechanisms driving lung cancer in … into the pathogenesis of lung cancer in this population, …
Gene-environment interaction between exposure to smoky coal combustion and a polygenic risk score with the risk of lung cancer
B Blechter, L Portengen, K Wang, J Wong… - ISEE Conference …, 2024 - ehp.niehs.nih.gov
97 天前 - … In Xuanwei, China, the high lung cancer rate for never-smoking women … lung cancer,
and genetic susceptibility, with the risk of lung cancer in never-smoking women in Xuanwei.…
and genetic susceptibility, with the risk of lung cancer in never-smoking women in Xuanwei.…
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
H Wang, Z Yao, K Kang, L Zhou, W Xiu, J Sun, C Xie… - Med, 2024 - cell.com
126 天前 - Background Immune checkpoint inhibitors (ICIs) provide modest but unsatisfactory
benefits for extensive-stage small cell lung cancer (ES-SCLC). Developing strategies for …
benefits for extensive-stage small cell lung cancer (ES-SCLC). Developing strategies for …
[HTML][HTML] … radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer
L Wang, Y Wu, K Kang, X Zhang, R Luo… - … Lung Cancer …, 2024 - ncbi.nlm.nih.gov
185 天前 - … Small cell lung cancer (SCLC), characterized by its rapid growth and early metastasis,
is the most aggressive subtype of lung cancer. Chemotherapy is the first-line treatment …
is the most aggressive subtype of lung cancer. Chemotherapy is the first-line treatment …